An Msh2 Point Mutation Uncouples DNA Mismatch Repair and Apoptosis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Research

• Publication date

  2004-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-03-2957PMID 14744764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The mismatch repair system is required for S-phase checkpoint activation

  2003cited by this paper
• Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility.

  2003cited by this paper
• Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin

  2003cited by this paper
• Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation.

  2002cited by this paper
• The mammalian mismatch repair pathway removes DNA 8-oxodGMP incorporated from the oxidized dNTP pool.

  2002cited by this paper
• Mbd4 inactivation increases C→T transition mutations and promotes gastrointestinal tumor formation

  2002cited by this paper
• DNA Repair and Tumorigenesis: Lessons from Hereditary Cancer Syndromes

  2002cited by this paper
• 1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.

  2001cited by this paper
• The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis.

  2001cited by this paper
• The distinct spectra of tumor-associated Apc mutations in mismatch repair-deficient Apc1638N mice define the roles of MSH3 and MSH6 in DNA repair and intestinal tumorigenesis.

  2001cited by this paper
• Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients

  2000cited by this paper
• Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA

  2000cited by this paper
• Somatic Apc mutations are selected upon their capacity to inactivate the β‐catenin downregulating activity

  2000cited by this paper
• The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

  1999cited by this paper
• Apoptosis induced by overexpression of hMSH2 or hMLH1.

  1999cited by this paper
• Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents.

  1999cited by this paper
• Mammalian DNA mismatch repair.

  1999cited by this paper
• Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine.

  1999cited by this paper
• MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-guanine in S. cerevisiae.

  1999cited by this paper
• The role of mismatch repair in DNA damage-induced apoptosis.

  1999cited by this paper
• Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene.

  1999cited by this paper
• Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha.

  1998cited by this paper
• Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent.

  1998cited by this paper
• A new logic for DNA engineering using recombination in Escherichia coli

  1998cited by this paper
• Mouse models for hereditary nonpolyposis colorectal cancer.

  1998cited by this paper
• Isolation of MutSβ from Human Cells and Comparison of the Mismatch Repair Specificities of MutSβ and MutSα*

  1998cited by this paper
• Functional overlap in mismatch repair by human MSH3 and MSH6.

  1998cited by this paper
• hMSH2 and hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMutSα

  1998cited by this paper
• Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus.

  1998cited by this paper
• Involvement of the mismatch repair system in temozolomide-induced apoptosis.

  1998cited by this paper
• Interactions of Human hMSH2 with hMSH3 and hMSH2 with hMSH6: Examination of Mutations Found in Hereditary Nonpolyposis Colorectal Cancer

  1998cited by this paper
• Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer.

  1997cited by this paper
• Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6.

  1997cited by this paper
• Strand-specific Mismatch Repair in Mammalian Cells*

  1997cited by this paper
• Genetic and biochemical analysis of Msh2p-Msh6p: role of ATP hydrolysis and Msh2p-Msh6p subunit interactions in mismatch base pair recognition

  1997cited by this paper
• In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.

  1997cited by this paper
• Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis.

  1996cited by this paper
• Biochemistry and genetics of eukaryotic mismatch repair.

  1996cited by this paper
• Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line*

  1996cited by this paper
• Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice.

  1996cited by this paper
• Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair.

  1996cited by this paper
• Loss of DNA mismatch repair in acquired resistance to cisplatin.

  1996cited by this paper
• Measurement of Heteroduplex Repair in Human Cell Extracts

  1995cited by this paper
• GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells.

  1995cited by this paper
• WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras.

  1995cited by this paper
• DNA damage tolerance, mismatch repair and genome instability

  1994cited by this paper
• Dominant negative mutator mutations in the mutS gene of Escherichia coli

  1994cited by this paper
• An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair.

  1993cited by this paper
• The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

  1991cited by this paper
• Heteroduplex repair in extracts of human HeLa cells.

  1991cited by this paper
• Superfamily of UvrA-related NTP-binding proteins. Implications for rational classification of recombination/repair systems.

  1990cited by this paper
• Refined crystal structure of the triphosphate conformation of H‐ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis.

  1990cited by this paper
• Distantly related sequences in the alpha‐ and beta‐subunits of ATP synthase, myosin, kinases and other ATP‐requiring enzymes and a common nucleotide binding fold.

  1982cited by this paper
• Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.

  1981cited by this paper

• Divergent accumulation patterns of SNVs and INDELs reveal negative selection in noncancerous cells

  2025influential citation
• Advances in diagnostic and therapeutic applications of mismatch repair loss in cancer

  2025cites this paper
• TREX2 deficiency suppresses spontaneous and genotoxin-associated mutagenesis

  2024cites this paper
• The Versatile Attributes of MGMT: Its Repair Mechanism, Crosstalk with Other DNA Repair Pathways, and Its Role in Cancer

  2024cites this paper
• Nonrepair functions of DNA mismatch repair proteins: new avenues for precision oncology.

  2024cites this paper
• Negative Selection Allows DNA Mismatch Repair-Deficient Mouse Fibroblasts In Vitro to Tolerate High Levels of Somatic Mutations

  2024influential citation
• Genetically engineered mouse models for hereditary cancer syndromes

  2023cites this paper
• Mismatch Repair Protein Msh2 Is Necessary for Macronuclear Stability and Micronuclear Division in Tetrahymena thermophila

  2023cites this paper
• Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation

  2023cites this paper
• Identification PMS1 and PMS2 as potential meiotic substrates of CDK2 activity

  2023cites this paper
• Therapeutic Targeting of DNA Replication Stress in Cancer

  2023cites this paper
• Loss of mismatch repair promotes a direct selective advantage in human stem cells

  2022cites this paper
• CNOT6: A Novel Regulator of DNA Mismatch Repair

  2022cites this paper
• Role of FOXO protein's abnormal activation through PI3K/AKT pathway in platinum resistance of ovarian cancer

  2021cites this paper
• Platinum Complexes in Colorectal Cancer and Other Solid Tumors

  2021cites this paper
• CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancer

  2021cites this paper
• Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy

  2021cites this paper
• Identification of Candidate Genes in Early-Stage Invasive Ductal Carcinoma Patients with High-Risk Mortality Using Genes Commonly Involved in Breast Cancer: A Retrospective Study

  2021cites this paper
• DNA alkylation lesion repair: outcomes and implications in cancer chemotherapy

  2021cites this paper
• SLX4 dampens MutSα-dependent mismatch repair

  2021cites this paper
• MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression

  2020cites this paper
• MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression

  2020cites this paper
• General Discussion and Future Perspectives

  2019cites this paper
• Functional interrogation of Lynch syndrome‐associated MSH2 missense variants via CRISPR‐Cas9 gene editing in human embryonic stem cells

  2019cites this paper
• Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.

  2019cites this paper
• The mismatch repair-dependent DNA damage response: Mechanisms and implications.

  2019cites this paper
• Methylation Tolerance-based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.

  2019cites this paper
• Differential genomic destabilisation in human cells with pathogenic MSH2 mutations introduced by genome editing

  2019cites this paper
• Human Mutation

  2019cites this paper
• Deficiency in the DNA glycosylases UNG1 and OGG1 does not potentiate c-Myc-induced B-cell lymphomagenesis.

  2018cites this paper
• Chapter 2 Mouse Models of Intestinal Cancer

  2017cites this paper
• Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells

  2017cites this paper
• 7 DNA Damage , Repair and Misrepair in Cancer And in Cancer Therapy

  2017cites this paper
• An Msh3 ATPase domain mutation has no effect on MMR function

  2017cites this paper
• Potential Strategies to Target Protein-Protein Interactions in the DNA Damage Response and Repair Pathways.

  2017cites this paper
• Functional analysis of rare variants in mismatch repair proteins augments results from computation-based predictive methods

  2017cites this paper
• Approaches to diagnose DNA mismatch repair gene defects in cancer.

  2016cites this paper
• Manipulation of DNA Repair Proficiency in Mouse Models of Colorectal Cancer

  2016influential citation
• Enhanced gene targeting to evaluate Lynch syndrome alterations

  2016cites this paper
• Mouse models of DNA mismatch repair in cancer research.

  2016cites this paper
• DNA mismatch repair and the DNA damage response.

  2016cites this paper
• Msh2-deficiency Affects the Differentiation and Proliferation of Small Intestinal Epithelial Cells

  2016cites this paper
• Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants

  2016cites this paper
• Commutation ou extinction de l'expression du BCR et impact sur la cellule B

  2015cites this paper
• Activating the MSH2/MSH6 Apoptotic Pathway in Cancer Cells Using Non-Reserpine Compounds

  2015cites this paper
• DNA Damage Response Pathways in Cancer Predisposition and Progression

  2015cites this paper
• Detection of coding microsatellite frameshift mutations in DNA mismatch repair‐deficient mouse intestinal tumors

  2015cites this paper
• Somatic Hypermutation: The Molecular Mechanisms Underlying the Production of Effective High-Affinity Antibodies

  2015cites this paper
• Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.

  2015cites this paper
• INSIGHT FROM AID-INDUCED DNA DAMAGE RESOLUTION: CELLULAR CONTEXT MATTERS

  2015cites this paper
• Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.

  2015cites this paper
• Mismatch repair during homologous and homeologous recombination.

  2015cites this paper
• BIOCHEMICAL EFFECTS OF INHERITED MMR GENE MUTATIONS AND DIET ON COLON CANCER RISK

  2014cites this paper
• The dual nature of mismatch repair as antimutator and mutator: for better or for worse

  2014cites this paper
• The Role of Base Excision Repair and Mismatch Repair Proteins in the Processing of Cisplatin Interstrand Cross-Links

  2014influential citation
• CARACTERIZAÇÃO FUNCIONAL DE VARIANTES DE PATOGENICIDADE INCERTA, MLH1 Leu676Pro E MSH2 Met729Ile, ENCONTRADAS EM PACIENTES DIAGNOSTICADOS COM SÍNDROME DE LYNCH

  2014cites this paper
• Expression of MSH2 and MSH6 on a tissue microarray in patients with osteosarcoma.

  2014cites this paper
• The study of interactions between antitumor effective heavy metal complexes with biomacromolecules using molecular biophysics methods

  2013cites this paper
• Major Differences between Tumor and Normal Human Cell Fates after Exposure to Chemotherapeutic Monofunctional Alkylator

  2013influential citation
• Acidic tumor microenvironment downregulates hMLH1 but does not diminish 5-fluorouracil chemosensitivity.

  2013cites this paper
• Mismatch repair proteins in recurrent prostate cancer.

  2013cites this paper
• Methylguanine DNA lesions induce an intra-S-phase arrest from which cells exit into apoptosis governed by early and late multi-pathway signaling

  2013cites this paper
• Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities.

  2013influential citation
• DNA Alterations in Lynch Syndrome

  2013cites this paper
• Transcription pattern of p53-targeted DNA repair genes in the hypoxia-tolerant subterranean mole rat Spalax.

  2013cites this paper
• Molecular Mechanisms and Functions of DNA Mismatch Repair

  2013cites this paper
• Single-molecule FRET Studies on DNA Mismatch Repair

  2013cites this paper
• Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth.

  2013cites this paper
• Interaction studies of muts and mutl with DNA containing the major cisplatin lesion and its mismatched counterpart under equilibrium and nonequilibrium conditions.

  2013cites this paper
• Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicity

  2013cites this paper
• 212 Shifting interfaces: changes in protein–protein and protein–DNA interfaces probed via molecular dynamics

  2013cites this paper
• Biochemical Analysis of the Human Mismatch Repair Proteins hMutSα MSH2G674A-MSH6 and MSH2-MSH6T1219D*

  2012influential citation
• Determining the functional significance of mismatch repair gene missense variants using biochemical and cellular assays

  2012cites this paper
• Exonuclease 1 (Exo1) is required for activating response to S(N)1 DNA methylating agents.

  2012influential citation
• Assessment of Missense Alterations in MLH1 and their Pathogenic Significance

  2012cites this paper
• Defective DNA Mismatch Repair-dependent c-Abl-p73-GADD45α Expression Confers Cancer Chemoresistance

  2012cites this paper
• The molecular origin of the MMR-dependent apoptosis pathway from dynamics analysis of MutSα-DNA complexes

  2012influential citation
• Molecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancer.

  2012cites this paper
• Identifying and Targeting Cellular Mechanisms to Enhance Cisplatin Chemotherapeutic Response in Cancer

  2012cites this paper
• Biochemical Analysis oftheHuman Mismatch Repair Proteins hMutS MSH2 G674A -MSH6 and MSH2-MSH6 T1219D * □

  2012cites this paper
• O6-Methylguanine DNA lesions induce an intra-S-phase arrest from which cells exit into apoptosis governed by early and late multi-pathway signaling network activation.

  2012cites this paper
• Transgenic Animal Models of Gastrointestinal Function

  2012cites this paper
• Pathological assessment of mismatch repair gene variants in Lynch syndrome: Past, present, and future

  2012cites this paper
• The predicted truncation from a cancer‐associated variant of the MSH2 initiation codon alters activity of the MSH2‐MSH6 mismatch repair complex

  2012cites this paper
• Insights into Protein—DNA Interactions, Stability and Allosteric Communications: A Computational Study of Mutsα-DNA Recognition Complexes

  2012cites this paper
• Animal Models of Colitis-Associated Carcinogenesis

  2011cites this paper
• Trypanosoma cruzi MSH2: Functional analyses on different parasite strains provide evidences for a role on the oxidative stress response

  2011cites this paper
• Mismatch and base excision repair proficiency in murine embryonic stem cells.

  2011cites this paper
• Phosphorylated hMSH6: DNA mismatch versus DNA damage recognition.

  2011cites this paper
• The Homologous Recombination Protein RAD51D Mediates the Processing of 6-Thioguanine Lesions Downstream of Mismatch Repair

  2011cites this paper
• DNA mismatch repair and cellular response to cytarabine : implications for the pathogenesis and treatment of therapy-related acute myeloid leukaemia

  2011cites this paper
• Mismatch-mediated error prone repair at the immunoglobulin genes.

  2011cites this paper
• Loss of DNA Mismatch Repair Imparts a Selective Advantage in Planarian Adult Stem Cells

  2011cites this paper
• Effects of suppressing the DNA mismatch repair system on homeologous recombination in tomato

  2011cites this paper
• DNA Damage and Cellular Stress Responses The Homologous Recombination Protein RAD 51 D Mediates the Processing of 6-Thioguanine Lesions Downstream of Mismatch Repair

  2011cites this paper
• DNA Damage, Repair and Misrepair in Cancer and in Cancer Therapy

  2011cites this paper
• DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells

  2011cites this paper
• Cell-based phenotypic screens to identify modulators of sensitivity to N-methyl-N'-nitro-N-nitrosoguanidine

  2011cites this paper
• UNG-initiated base excision repair is the major repair route for 5-fluorouracil in DNA, but 5-fluorouracil cytotoxicity depends mainly on RNA incorporation

  2011cites this paper
• Mouse models of inherited cancer syndromes.

  2010cites this paper